Profile
Eventide Asset Management is an investment firm based in Boston, MA. They focus on mutual funds and are known for their values-based approach to investing, which emphasizes integrity and impact. The firm aims to create value for stakeholders while pursuing outperformance in the market.
Eventide invests across various sectors, including healthcare, technology, and life sciences, with a range of mutual funds designed for different investment objectives. Their offerings include funds focused on dividend growth, large-cap stocks, and balanced portfolios. The firm provides investment solutions for individual investors, financial advisors, and institutional clients.
Notable investments include Eventide Dividend Growth Fund - dividend paying stocks, Eventide Large Cap Focus Fund - large market capitalization, Eventide Gilead Fund - healthcare and IT, Eventide Healthcare & Life Sciences Fund - drug-related industries, and Eventide Exponential Technologies Fund - information technology and communication sectors.
Industry
Eventide Asset Management Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Eventide Healthcare & Life Sciences Fund (ETIHX)
|
Fund of funds
|
Healthcare Services
Medical Devices
HealthTech
|
Pre-seed
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
—
|
December 2012
|
|
Eventide Exponential Technologies Fund (ETIEX)
|
Fund of funds
|
Technology
|
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
—
|
June 2020
|
|
Eventide Dividend Growth Fund
|
Venture Capital (VC)
|
MedTech
Software
SaaS
Pharmaceuticals
Medical Devices
IT Services
Healthcare Services
Foodtech
Food and Beverage
Fintech
Education
Biotechnology
Technology
Life Sciences
Infrastructure
Energy
Cybersecurity
Internet of Things (IoT)
HealthTech
|
Seed
Series B
Series A
|
North America
Europe
|
$1-5 m
|
—
|
September 2026
|
|
Eventide Large Cap Focus Fund
|
Venture Capital (VC)
|
MedTech
Software
SaaS
Pharmaceuticals
Medical Devices
IT Services
Healthcare Services
Foodtech
Food and Beverage
Fintech
Education
Biotechnology
Technology
Life Sciences
Infrastructure
Energy
Cybersecurity
Internet of Things (IoT)
HealthTech
|
Seed
Series B
Series A
|
North America
Europe
|
$1-5 m
|
—
|
September 2026
|
|
Eventide Gilead Fund
|
Venture Capital (VC)
|
MedTech
Software
SaaS
Pharmaceuticals
Medical Devices
IT Services
Healthcare Services
Foodtech
Food and Beverage
Fintech
Education
Biotechnology
Technology
Life Sciences
Infrastructure
Energy
Cybersecurity
Internet of Things (IoT)
HealthTech
|
Seed
Series B
Series A
|
North America
Europe
|
$1-5 m
|
—
|
September 2026
|
|
Eventide Balanced Fund
|
Venture Capital (VC)
|
MedTech
Software
SaaS
Pharmaceuticals
Medical Devices
IT Services
Healthcare Services
Foodtech
Food and Beverage
Fintech
Education
Biotechnology
Technology
Life Sciences
Infrastructure
Energy
Cybersecurity
Internet of Things (IoT)
HealthTech
|
Seed
Series B
Series A
|
North America
Europe
|
$1-5 m
|
—
|
September 2026
|
|
Eventide Limited-Term Bond Fund
|
Venture Capital (VC)
|
MedTech
Software
SaaS
Pharmaceuticals
Medical Devices
IT Services
Healthcare Services
Foodtech
Food and Beverage
Fintech
Education
Biotechnology
Technology
Life Sciences
Infrastructure
Energy
Cybersecurity
Internet of Things (IoT)
HealthTech
|
Seed
Series B
Series A
|
North America
Europe
|
$1-5 m
|
—
|
September 2026
|
|
Eventide Core Bond Fund
|
Venture Capital (VC)
|
MedTech
Software
SaaS
Pharmaceuticals
Medical Devices
IT Services
Healthcare Services
Foodtech
Food and Beverage
Fintech
Education
Biotechnology
Technology
Life Sciences
Infrastructure
Energy
Cybersecurity
Internet of Things (IoT)
HealthTech
|
Seed
Series B
Series A
|
North America
Europe
|
$1-5 m
|
—
|
September 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.